{"id":"https://openalex.org/W2617492002","doi":"https://doi.org/10.1182/blood.v128.22.5218.5218","title":"A Phase I Study of the Multi-Targeted Tyrosine Kinase Inhibitor Cabozantinib in Patients with Acute Myeloid Leukemia","display_name":"A Phase I Study of the Multi-Targeted Tyrosine Kinase Inhibitor Cabozantinib in Patients with Acute Myeloid Leukemia","publication_year":2016,"publication_date":"2016-12-02","ids":{"openalex":"https://openalex.org/W2617492002","doi":"https://doi.org/10.1182/blood.v128.22.5218.5218","mag":"2617492002"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v128.22.5218.5218","doi":"https://doi.org/10.1182/blood.v128.22.5218.5218","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.5218.5218","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010057352","display_name":"Amir Tahmasb Fathi","orcid":"https://orcid.org/0000-0003-4907-6447","observed_orcids":["https://orcid.org/0000-0003-4907-6447"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amir T. Fathi","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071293141","display_name":"Traci M. Blonquist","orcid":"https://orcid.org/0000-0003-1346-988X","observed_orcids":["https://orcid.org/0000-0003-1346-988X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Traci M. Blonquist","raw_affiliation_strings":["Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089694123","display_name":"Mark J. Levis","orcid":"https://orcid.org/0000-0003-0473-6982","observed_orcids":["https://orcid.org/0000-0003-0473-6982","https://orcid.org/0000-0003-4219-6315"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark J. Levis","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067960397","display_name":"Daniela Hernandez","orcid":"https://orcid.org/0000-0001-5960-160X","observed_orcids":["https://orcid.org/0000-0001-5960-160X"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daniela Hernandez","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045583767","display_name":"Karen Kuhn Ballen","orcid":"https://orcid.org/0000-0003-1706-3975","observed_orcids":["https://orcid.org/0000-0003-1706-3975"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen K. Ballen","raw_affiliation_strings":["Massachusetts General Hospital / Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital / Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052641327","display_name":"David Avigan","orcid":"https://orcid.org/0000-0003-4624-6017","observed_orcids":["https://orcid.org/0000-0003-4624-6017"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David E. Avigan","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028590331","display_name":"Robin Joyce","orcid":"https://orcid.org/0000-0002-7251-8082","observed_orcids":["https://orcid.org/0000-0002-7251-8082"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robin Joyce","raw_affiliation_strings":["Beth Israel Deaconess Medical Center / Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center / Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067994799","display_name":"Malgorzata McMasters","orcid":"https://orcid.org/0009-0000-1327-0948","observed_orcids":["https://orcid.org/0009-0000-1327-0948"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Malgorzata McMasters","raw_affiliation_strings":["Beth Israel Deaconess Medical Center / Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center / Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085692402","display_name":"Emma K. Logan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Emma Logan","raw_affiliation_strings":["Beth Israel Deaconess Medical Center / Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center / Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065595440","display_name":"Gabriela Soriano Hobbs","orcid":"https://orcid.org/0000-0002-0199-9333","observed_orcids":["https://orcid.org/0000-0002-0199-9333"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriela S. Hobbs","raw_affiliation_strings":["Massachusetts General Hospital / Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital / Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009387581","display_name":"Andrew Mark Brunner","orcid":"https://orcid.org/0000-0002-2169-4115","observed_orcids":["https://orcid.org/0000-0002-2169-4115"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew M. Brunner","raw_affiliation_strings":["Massachusetts General Hospital / Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital / Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063064811","display_name":"Christine Apour Connolly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Christine Connolly","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074239788","display_name":"Ashley Marie Perry","orcid":"https://orcid.org/0000-0003-1209-6030","observed_orcids":["https://orcid.org/0000-0003-1209-6030"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashley M. Perry","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112399559","display_name":"Christelle P. Joseph","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Christelle Joseph","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081484812","display_name":"Tina T. Som","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Tina T. Som","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100551706","display_name":"Aura Y. Ramos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Aura Y. Ramos","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003947352","display_name":"Donna S Neuberg","orcid":"https://orcid.org/0000-0003-2566-3145","observed_orcids":["https://orcid.org/0000-0003-2566-3145"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donna S. Neuberg","raw_affiliation_strings":["Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009091754","display_name":"Philip C. Amrein","orcid":"https://orcid.org/0000-0001-7770-2623","observed_orcids":["https://orcid.org/0000-0001-7770-2623"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip C. Amrein","raw_affiliation_strings":["Massachusetts General Hospital / Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital / Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5063064811","https://openalex.org/A5067960397","https://openalex.org/A5067994799","https://openalex.org/A5071293141","https://openalex.org/A5081484812","https://openalex.org/A5085692402","https://openalex.org/A5100551706","https://openalex.org/A5112399559"],"corresponding_institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984","https://openalex.org/I145311948","https://openalex.org/I4210087915","https://openalex.org/I4210117453","https://openalex.org/I4210164401"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.19546172,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":95},"biblio":{"volume":"128","issue":"22","first_page":"5218","last_page":"5218"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cabozantinib","display_name":"cabozantinib","score":0.9879999756813049},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9869999885559082},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9279999732971191},{"id":"https://openalex.org/keywords/flt3-itd-mutation","display_name":"FLT3-ITD","score":0.7820000052452087},{"id":"https://openalex.org/keywords/flt3","display_name":"FLT3","score":0.46399998664855957},{"id":"https://openalex.org/keywords/met","display_name":"MET","score":0.7009999752044678},{"id":"https://openalex.org/keywords/axl","display_name":"AXL","score":0.9610000252723694},{"id":"https://openalex.org/keywords/vegfr","display_name":"VEGFR","score":0.9879999756813049},{"id":"https://openalex.org/keywords/kit","display_name":"KIT","score":0.9940000176429749},{"id":"https://openalex.org/keywords/relapsed-refractory-aml","display_name":"relapsed/refractory AML","score":0.8429999947547913},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8289999961853027},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9850000143051147},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.859000027179718},{"id":"https://openalex.org/keywords/hydroxyurea","display_name":"hydroxyurea","score":0.734000027179718},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.4860000014305115}],"concepts":[{"id":"https://openalex.org/C2781064419","wikidata":"https://www.wikidata.org/wiki/Q795057","display_name":"Cabozantinib","level":3,"score":0.8772992491722107},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7823500633239746},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5964808464050293},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5947153568267822},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5923972129821777},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5507503747940063},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5252392292022705},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.46229714155197144},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40965133905410767},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3332374691963196},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3061724305152893},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v128.22.5218.5218","doi":"https://doi.org/10.1182/blood.v128.22.5218.5218","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.5218.5218","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8299999833106995,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2087016115","https://openalex.org/W2349164817","https://openalex.org/W4361814033","https://openalex.org/W4361814189","https://openalex.org/W3081300756","https://openalex.org/W4361813995","https://openalex.org/W4361814184","https://openalex.org/W2623312887","https://openalex.org/W4361813994","https://openalex.org/W2522724984"],"abstract_inverted_index":{"Abstract":[0],"Cabozantinib":[1,29,192],"is":[2,40,643,699],"a":[3,144,181,245,563,572,593,640,683],"multi-targeted":[4,641],"tyrosine":[5,680],"kinase":[6,681],"inhibitor":[7],"(TKI)":[8],"of":[9,17,24,36,66,83,91,107,150,168,222,230,235,244,271,299,354,367,381,419,460,471,579,607,626,636,652,663,691],"FLT3,":[10],"MET,":[11],"AXL,":[12],"VEGFR,":[13],"and":[14,39,48,70,81,199,273,284,319,332,343,399,438,474,492,507,537,548,598,623,685],"KIT,":[15],"all":[16],"which":[18],"are":[19],"implicated":[20],"in":[21,33,45,62,73,85,109,188,195,257,328,335,513,574,595,629,645,682],"the":[22,79,102,164,268,375,408,413,420,425,439,451,466,475,505,616,650],"pathogenesis":[23],"acute":[25],"myeloid":[26],"leukemia":[27],"(AML).":[28],"has":[30,57],"been":[31,59,360],"studied":[32,61,415],"clinical":[34,285,666,689],"trials":[35],"solid":[37,189],"tumors,":[38],"FDA":[41],"approved":[42],"for":[43,136,396,556],"use":[44,243],"medullary":[46],"thyroid":[47],"renal":[49],"cell":[50,147,631],"carcinoma.":[51],"Despite":[52],"multiple":[53],"relevant":[54],"targets,":[55],"cabozantinib":[56,84,108,669,677,692],"not":[58,393,464],"previously":[60,183],"AML.":[63,112],"Given":[64],"up-regulation":[65],"these":[67],"key":[68],"enzymes":[69],"related":[71,528],"pathways":[72],"AML,":[74,124,342],"we":[75,674],"sought":[76],"to":[77,100,160,185,213,252,389,478,484,503,529,668],"assess":[78,253],"safety":[80],"tolerability":[82],"this":[86,92,397,518,657],"population.":[87],"The":[88,171,308,351],"primary":[89],"objective":[90],"phase":[93],"I,":[94],"3+3":[95],"cohort":[96,516],"dose-escalation":[97],"study":[98,231,290,485,690],"was":[99,158,175,193,218,250,261,311,400,500,671],"define":[101],"maximum":[103],"tolerated":[104],"dose":[105,173,182,200,216,223,377,410,427,455],"(MTD)":[106],"patients":[110,303,338,345,371,422,446,489,509,552,561,570,646,694],"with":[111,119,130,156,281,356,362,434,441,588,647,695],"Eligibility":[113],"included":[114,538],"adults":[115],"\u2265":[116,128,521],"age":[117,310],"18,":[118],"relapsed":[120],"or":[121,125,137,277,280,296,364,526,534],"refractory":[122],"(R/R)":[123],"those":[126,274,355],"aged":[127],"70,":[129],"new":[131],"diagnosed":[132,349],"AML":[133,358,648,664,698],"but":[134,153,391],"ineligible":[135],"declining":[138],"conventional":[139],"therapy.":[140],"Study":[141],"treatment":[142,155],"required":[143],"white":[145],"blood":[146],"count":[148],"(WBC)":[149],"<":[151],"30,000/mm3,":[152],"concurrent":[154],"hydroxyurea":[157],"allowed":[159],"control":[161],"WBC":[162],"during":[163,227,577],"first":[165,172,269,376,409],"15":[166],"days":[167],"cycle":[169,228,270,637],"1.":[170,638],"level":[174,217,378,411,428,456],"40MG":[176,498],"by":[177,220,242,263,615,633],"mouth":[178],"daily":[179,499],"(QD),":[180],"demonstrated":[184],"be":[186,394,504,554],"well-tolerated":[187,644],"tumor":[190],"malignancies.":[191],"administered":[194],"28":[196],"day":[197,634],"cycles,":[198],"escalation":[201],"occurred":[202],"via":[203],"3":[204,370,436,443,533],"cohorts":[205],"(40MG":[206,379,458],"QD,":[207,209],"60MG":[208],"80MG":[210],"QD).":[211],"Escalation":[212],"each":[214,531],"successive":[215],"guided":[219],"incidence":[221],"limiting":[224],"toxicity":[225],"(DLT)":[226],"1":[229,457],"treatment.":[232,369,486],"Pharmacodynamic":[233],"evaluation":[234],"serial":[236],"plasma":[237,246,611],"samples":[238],"obtained":[239],"from":[240],"patients,":[241,331,536,665],"inhibitory":[247,255,605],"assay":[248],"(PIA),":[249],"used":[251],"FLT3":[254,604,627,696],"activity":[256,606],"FLT3-ITDcell":[258],"lines.":[259],"Response":[260],"determined":[262,502,614],"bone":[264],"marrow":[265,564,596,602],"biopsy":[266],"after":[267],"treatment,":[272,578],"achieving":[275],"complete":[276,465],"partial":[278],"remission,":[279],"stable":[282,601],"disease":[283,292,472],"benefit,":[286],"could":[287,392,463,553],"continue":[288],"on":[289,306,558],"until":[291],"progression,":[293],"intolerable":[294],"toxicity,":[295],"upon":[297],"receipt":[298],"12":[300,315],"cycles.":[301],"18":[302],"were":[304,317,322,326,372,405,447,490,496,510],"enrolled":[305,373,423,449],"study.":[307,559],"median":[309],"68":[312],"(range":[313],"27-85);":[314],"(67%)":[316],"male,":[318],"14":[320],"(78%)":[321],"Caucasian.":[323],"FLT3-ITD":[324,679],"mutations":[325,334],"detected":[327,406],"5":[329],"(23%)":[330],"NPM1":[333],"none.":[336],"16":[337],"(89%)":[339],"had":[340,347,359,562,571,600],"R/R":[341,357],"2":[344,523,581],"(11%)":[346],"newly":[348],"disease.":[350,603],"majority":[352],"(75%)":[353],"treated":[361,512],"two":[363,418,462,488],"more":[365],"lines":[366,632],"prior":[368],"at":[374,407,424,450,517,649],"QD),":[380,459],"whom":[382,461,580],"one":[383,433,469,599],"experienced":[384,431,592],">G3":[385],"transaminitis,":[386,547],"thought":[387],"unrelated":[388,483],"cabozantinib,":[390,530],"dosed":[395],"reason":[398],"therefore":[401,501,700],"replaced.":[402],"No":[403,560],"DLTs":[404,495],"among":[412,693],"4":[414],"patients.":[416],"However,":[417,673],"three":[421],"second":[426],"(60MG":[429],"QD)":[430],"DLT,":[432],"grade":[435,442,522],"pancreatitis":[437],"other":[440,476],"transaminitis.":[444],"Three":[445],"then":[448],"next":[452],"lower":[453],"level,":[454],"DLT":[467],"period,":[468],"because":[470],"progression":[473],"due":[477],"an":[479,514],"infected":[480],"aortic":[481],"ulceration":[482],"These":[487],"replaced,":[491],"no":[493],"additional":[494],"noted.":[497],"MTD,":[506],"6":[508],"subsequently":[511],"expansion":[515],"dose.":[519],"Additional":[520,688],"toxicities,":[524],"possibly":[525],"probably":[527],"affected":[532],"less":[535],"fatigue,":[539],"nausea,":[540],"anorexia,":[541],"constipation,":[542],"oral":[543],"mucositis,":[544],"palmar-plantar":[545],"erythrodysesthesia,":[546],"electrolyte":[549],"imbalance.":[550],"Fifteen":[551],"assessed":[555],"response":[557,565,667],"per":[566],"formal":[567],"criteria.":[568],"Four":[569],"reduction":[573,594],"peripheral":[575],"blasts":[576,586],"transiently":[582],"cleared":[583],"their":[584],"circulating":[585],"(one":[587],"FLT3-ITD).":[589],"One":[590],"patient":[591,610],"blasts,":[597],"serially":[608],"collected":[609],"samples,":[612],"as":[613],"ex":[617],"vivo":[618],"PIA,":[619],"consistently":[620],"revealed":[621],"potent":[622,684],"sustained":[624,686],"inhibition":[625],"auto-phosphorylation":[628],"FLT3-ITDmutant":[630],"8":[635],"Cabozantinib,":[639],"TKI,":[642],"MTD":[651],"40":[653],"MG":[654],"daily.":[655],"In":[656],"molecularly":[658],"heterogeneous,":[659],"heavily":[660],"pre-treated":[661],"population":[662],"monotherapy":[670],"limited.":[672],"found":[675],"that":[676],"inhibits":[678],"fashion.":[687],"mutant":[697],"warranted.":[701],"Disclosures":[702],"Fathi:":[703],"Celgene:":[704],"Consultancy,":[705,715,734,738,743,746],"Research":[706,720,735,740,748,751,754],"Funding;":[707,721,736,741,752],"Merck:":[708],"Other:":[709,716,724,729,757,762],"Advisory":[710,717,725,730,758,763],"Board":[711,718,726,731,759,764],"participation;":[712,727,760],"Seattle":[713],"Genetics:":[714],"participation,":[719],"Agios":[722],"Pharmaceuticals:":[723],"Bexalata:":[728],"participation.":[732,765],"Levis:Millennium:":[733],"Novartis:":[737],"Honoraria,":[739,747],"Daiichi-Sankyo:":[742],"Honoraria;":[744],"Astellas:":[745],"Funding.":[749,755],"Avigan:Astex:":[750],"DCPrime:":[753],"Hobbs:Constellation:":[756],"Incyte:":[761]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2025-10-10T00:00:00"}